|Day Low/High||16.96 / 16.98|
|52 Wk Low/High||3.02 / 17.05|
--ONZETRA Xsail is the first breath-powered intranasal medication delivery system for the acute treatment of migraine--
-- First Study to Evaluate the Prevalence of PBA Symptoms in Nursing Home Residents Found Almost 1 in 10 Residents Had Symptoms of PBA; These Patients with PBA Symptoms were Twice as Likely to Receive Antipsychotics --
-- AVP-786 Granted FDA Fast Track Designation for This Indication --
--New Data Demonstrate Treatment Effects on Pseudobulbar Affect (PBA) with NUEDEXTA Regardless of Concomitant Antidepressant Use--
-- Results Show NUEDEXTA Provides Meaningful Reduction of PBA Episodes and is Generally Well Tolerated in PBA Patients Who Had an Underlying Stroke or Traumatic Brain Injury --
-- Ninety nine percent of respondents experienced some form of brain trauma during their playing career and one third also report symptoms of PBA --
--Avanir Pharmaceuticals Takes Unique Approach to Patient Education in New Initiative--
'Tackle PBA,' a New Educational Campaign, Addresses Why Many Former Pro Football Players Cry or Laugh Uncontrollably with Little to No Clear Trigger
--Award-Winning Filmmakers Capture Untold Story of Little-Known Neurologic Condition That Affects Nearly 2 Million Americans--
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of...
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Avanir Pharmaceuticals, Inc.
In this era of turmoil, investors can take comfort in this sector.